David S. Liebeskind - Researcher Profile

Publications

3 shown

Trevo versus Merci retrievers for thrombectomy revascularisation of large vessel occlusions in acute ischaemic stroke (TREVO 2): a randomised trial

Raul G. Nogueira , Helmi L. Lutsep , Rishi Gupta +5 more

2012 The Lancet 1103 citations

Number Needed to Treat to Benefit and to Harm for Intravenous Tissue Plasminogen Activator Therapy in the 3- to 4.5-Hour Window

Jeffrey L. Saver , Jeffrey Gornbein , James C. Grotta +5 more

Background and Purpose— Measures of a therapy’s effect size are important guides to clinicians, patients, and policy-makers on treatment decisions in clinical practice. The ECAS...

2009 Stroke 120 citations

A collaborative sequential meta-analysis of individual patient data from randomized trials of endovascular therapy and tPA vs. tPA alone for acute ischemic stroke: ThRombEctomy And tPA (TREAT) analysis: statistical analysis plan for a sequential meta-analysis performed within the VISTA-Endovascular collaboration

Rachael MacIsaac , Pooja Khatri , Martin Bendszus +35 more

Rationale Endovascular treatment has been shown to restore blood flow effectively. Second-generation medical devices such as stent retrievers are now showing overwhelming effica...

2015 International Journal of Stroke 14 citations

Frequent Co-Authors

Researcher Info

h-index: 3
Publications: 3
Citations: 1,237
Institution: University of California, Los Angeles

External Links

ORCID Profile Google Scholar

Identifiers

ORCID: 0000-0002-5109-8736

Impact Metrics

h-index 3

h-index: Number of publications with at least h citations each.